Developer docs
API playgroundTry for free, no card

Search company profiles

Meridien Research

Full company profile

uuid0009d47

Namestring
Meridien Research
Legal namestring
Alcanza Clinical Research
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Meridien Research is a U.S. clinical research organization founded in 2000, headquartered in Winter Park, Florida, and operating within the broader Alcanza Clinical Research multisite network. The company conducts clinical trials on behalf of pharmaceutical and biotech sponsors, enrolling patients across an extensive therapeutic range spanning oncology, central nervous system disorders, cardiometabolic conditions, vaccines, women's health, dermatology, and many other indications. Meridien recruits patients through a community-led, direct-to-patient model that combines community-based outreach, health education, and medical provider referrals, supported by a website-based profile creation and trial finder system.

The company's underlying technology layer includes the ReachOne AI Toolbox, an AI-powered product offering hosted at reachone.ai that supports clinical research patient engagement and education. Meridien is part of the Alcanza network, which operates 26 dedicated clinical research facilities across 14 U.S. states and Puerto Rico and is a founding member of the Association of Multisite Research Corporations (AMRC), an alliance of 14 multisite research organizations spanning 400+ sites and nearly 1,000 Principal Investigators.

Meridien's revenue model is professional services: the company earns fees from pharmaceutical and biotech sponsors for patient enrollment, study execution, and data collection across all major therapeutic areas. Patient participation is offered at no cost with compensation for time and travel. Praveen Asthana serves as Founder and CEO. Specific sponsor client names, contract values, and revenue figures are not publicly disclosed.

Short descriptiontext

Meridien Research is a U.S. clinical research organization founded in 2000 in Winter Park, Florida, conducting clinical trials for pharmaceutical and biotech sponsors across a broad therapeutic range, operating within the Alcanza Clinical Research multisite network of 26 facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSt. Petersburg, United States
HQ citystring
St. Petersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices26 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, clinical trial conduct, patient recruitment, multisite research, clinical trial site network
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Alcanza generates revenue by conducting clinical trials on behalf of pharmaceutical and biotech sponsors. The company provides research services to a diverse patient population across all major therapeutic areas, earning fees for patient enrollment, study execution, and data collection.

alcanzaclinical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1ReachOne AI Toolbox
Description

AI-powered toolbox referenced as a product offering on the company's website

alcanzaclinical.com
Core offering1 text field

Meridien Research operates a dedicated clinical research facility in Winter Park that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. As a member site of the Alcanza Clinical Research network, it recruits and enrolls diverse patient populations across multiple therapeutic areas, executes study protocols, and collects clinical data for sponsors while providing participants with access to investigational treatments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 73,500+ patients enrolled in 2024 across AMRC network
Product overview1 text field

Alcanza Clinical Research is a clinical research organization providing inclusive clinical trial services. The company operates a network of dedicated clinical research facilities across the United States. Their main offering consists of clinical research services for patient participation in clinical trials, supplemented by the ReachOne AI Toolbox which appears to be an AI-powered patient engagement product. They collaborate with medical providers and community-based organizations to deliver clinical research opportunities.

Product and service2 records
1Clinical Trial Participation
CategoryClinical Research Services
Description

Participation in clinical research studies across all major therapeutic areas, offered to patients and healthy volunteers at no cost with compensation for time and travel. Served through Meridien Research's Winter Park, FL site within the Alcanza Clinical Research network.

2Clinical Research Services for Sponsors
CategoryClinical Research Services
Description

Site-based clinical trial execution on behalf of pharmaceutical and biotech sponsors, including patient enrollment, study execution, and data collection across diverse therapeutic areas and patient populations.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Association of Multisite Research Corporations (AMRC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Alcanza Clinical Research is a founding member of AMRC, a newly launched alliance of 14 prominent multisite research organizations. AMRC aims to transform clinical trial execution across the U.S. through collaboration, standardization, and data quality improvement. The network includes 400+ research sites, nearly 1,000 Principal Investigators, and 7,000+ research professionals. AMRC's mission includes minimizing delays impacting nearly 80% of clinical trials, improving operational efficiency for complex study designs, and strengthening collaboration to speed drug development.

alcanzaclinical.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parent multi-site clinical research network operating 26 sites across 14 states plus Puerto Rico. Meridien Research operates under the Alcanza banner, making Alcanza the direct operational umbrella and closest comparable for site-level activity.

TypeDirect peer
Description

One of the largest integrated SMO networks in the US, operating dedicated clinical research sites across multiple states. Competes with Alcanza/AMRC-affiliated sites for the same sponsor trial placements and patient populations.

TypeDirect peer
Description

Multi-site clinical research organization based in the southeastern US operating across therapeutic areas. Direct SMO peer with overlapping therapeutic breadth and community-based recruitment approach.

TypeDirect peer
Description

Multi-site clinical research organization with sites across the southeastern US. Directly comparable SMO serving the same sponsors, therapeutic categories, and patient populations.

TypeDirect peer
Description

Multi-site SMO focused on phase II–IV clinical trials across diverse therapeutic areas. Operates dedicated research sites competing for sponsor trial allocations, with similar community-outreach patient recruitment model.

TypeDirect peer
Description

Network of dedicated clinical research sites in the southeastern US covering multiple therapeutic areas. Operates with comparable patient-recruitment motion and sponsors across the same indications as Meridien.

7Research Across America
TypeDirect peer
Description

Multi-site SMO operating research facilities across multiple US states, primarily in the South and Midwest. Competes for sponsor trial placements with the same therapeutic-area breadth.

TypeBroad incumbent
Description

Largest global CRO with integrated site network. Operates as a broad incumbent whose site-management offerings overlap with Meridien's SMO services, serving the same pharma/biotech sponsors.

TypeBroad incumbent
Description

Mid-to-large global CRO running clinical trials across all major therapeutic areas. A broad incumbent whose site-management and full-service CRO offerings overlap with SMO activities.

TypeBroad incumbent
Description

Global CRO with post-PPD acquisition site relationships across the US. A broad incumbent with site-management capabilities and large sponsor contracts that overlap with Alcanza/Meridien's service offering.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Meridien Research

Clinical Research Servicesmeridienresearch.net

Meridien Research is a U.S. clinical research organization founded in 2000 in Winter Park, Florida, conducting clinical trials for pharmaceutical and biotech sponsors across a broad therapeutic range, operating within the Alcanza Clinical Research multisite network of 26 facilities.

What Meridien Research does

Meridien Research is a U.S. clinical research organization founded in 2000, headquartered in Winter Park, Florida, and operating within the broader Alcanza Clinical Research multisite network. The company conducts clinical trials on behalf of pharmaceutical and biotech sponsors, enrolling patients across an extensive therapeutic range spanning oncology, central nervous system disorders, cardiometabolic conditions, vaccines, women's health, dermatology, and many other indications. Meridien recruits patients through a community-led, direct-to-patient model that combines community-based outreach, health education, and medical provider referrals, supported by a website-based profile creation and trial finder system.

The company's underlying technology layer includes the ReachOne AI Toolbox, an AI-powered product offering hosted at reachone.ai that supports clinical research patient engagement and education. Meridien is part of the Alcanza network, which operates 26 dedicated clinical research facilities across 14 U.S. states and Puerto Rico and is a founding member of the Association of Multisite Research Corporations (AMRC), an alliance of 14 multisite research organizations spanning 400+ sites and nearly 1,000 Principal Investigators.

Meridien's revenue model is professional services: the company earns fees from pharmaceutical and biotech sponsors for patient enrollment, study execution, and data collection across all major therapeutic areas. Patient participation is offered at no cost with compensation for time and travel. Praveen Asthana serves as Founder and CEO. Specific sponsor client names, contract values, and revenue figures are not publicly disclosed.

Meridien Research firmographics

Firmographics
Name
Meridien Research
Legal name
Alcanza Clinical Research
Website
https://meridienresearch.net
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Meridien Research is a U.S. clinical research organization founded in 2000 in Winter Park, Florida, conducting clinical trials for pharmaceutical and biotech sponsors across a broad therapeutic range, operating within the Alcanza Clinical Research multisite network of 26 facilities.
Ownership category
akta.pro rank

Meridien Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Keywords

  • Clinical research services
  • Clinical trial conduct
  • Patient recruitment
  • Multisite research
  • Clinical trial site network

Where Meridien Research is headquartered

Location

Headquarters

HQ city
St. Petersburg
HQ country
United States
HQ region
North America

Offices26 records

Markets served

Meridien Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Alcanza generates revenue by conducting clinical trials on behalf of pharmaceutical and biotech sponsors. The company provides research services to a diverse patient population across all major therapeutic areas, earning fees for patient enrollment, study execution, and data collection.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Meridien Research product offering

Product offering

Core offering

Meridien Research operates a dedicated clinical research facility in Winter Park that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. As a member site of the Alcanza Clinical Research network, it recruits and enrolls diverse patient populations across multiple therapeutic areas, executes study protocols, and collects clinical data for sponsors while providing participants with access to investigational treatments.

Product overview

Alcanza Clinical Research is a clinical research organization providing inclusive clinical trial services. The company operates a network of dedicated clinical research facilities across the United States. Their main offering consists of clinical research services for patient participation in clinical trials, supplemented by the ReachOne AI Toolbox which appears to be an AI-powered patient engagement product. They collaborate with medical providers and community-based organizations to deliver clinical research opportunities.

Differentiator

Problem solved

Functional benefit

Brands

  • ReachOne AI Toolbox: AI-powered toolbox referenced as a product offering on the company's website

Products and services

  • Clinical Trial Participation Participation in clinical research studies across all major therapeutic areas, offered to patients and healthy volunteers at no cost with compensation for time and travel. Served through Meridien Research's Winter Park, FL site within the Alcanza Clinical Research network.
  • Clinical Research Services for Sponsors Site-based clinical trial execution on behalf of pharmaceutical and biotech sponsors, including patient enrollment, study execution, and data collection across diverse therapeutic areas and patient populations.

Quantifiable outcome

  • 73,500+ patients enrolled in 2024 across AMRC network

Companies that use Meridien Research

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Meridien Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Meridien Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Association of Multisite Research Corporations (AMRC)coreStrategic or Co-development Partner · 1 January 2024Alcanza Clinical Research is a founding member of AMRC, a newly launched alliance of 14 prominent multisite research organizations. AMRC aims to transform clinical trial execution across the U.S. through collaboration, standardization, and data quality improvement. The network includes 400+ research sites, nearly 1,000 Principal Investigators, and 7,000+ research professionals. AMRC's mission includes minimizing delays impacting nearly 80% of clinical trials, improving operational efficiency for complex study designs, and strengthening collaboration to speed drug development.

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Meridien Research competitors and assessment

Company assessment

Broad incumbents

  • Alcanza Clinical Research: Parent multi-site clinical research network operating 26 sites across 14 states plus Puerto Rico. Meridien Research operates under the Alcanza banner, making Alcanza the direct operational umbrella and closest comparable for site-level activity.
  • IQVIA: Largest global CRO with integrated site network. Operates as a broad incumbent whose site-management offerings overlap with Meridien's SMO services, serving the same pharma/biotech sponsors.
  • Medpace: Mid-to-large global CRO running clinical trials across all major therapeutic areas. A broad incumbent whose site-management and full-service CRO offerings overlap with SMO activities.
  • ICON plc: Global CRO with post-PPD acquisition site relationships across the US. A broad incumbent with site-management capabilities and large sponsor contracts that overlap with Alcanza/Meridien's service offering.

Direct peers

  • Velocity Clinical Research: One of the largest integrated SMO networks in the US, operating dedicated clinical research sites across multiple states. Competes with Alcanza/AMRC-affiliated sites for the same sponsor trial placements and patient populations.
  • Wake Research: Multi-site clinical research organization based in the southeastern US operating across therapeutic areas. Direct SMO peer with overlapping therapeutic breadth and community-based recruitment approach.
  • Flourish Research: Multi-site clinical research organization with sites across the southeastern US. Directly comparable SMO serving the same sponsors, therapeutic categories, and patient populations.
  • Benchmark Research: Multi-site SMO focused on phase II–IV clinical trials across diverse therapeutic areas. Operates dedicated research sites competing for sponsor trial allocations, with similar community-outreach patient recruitment model.
  • Accel Research: Network of dedicated clinical research sites in the southeastern US covering multiple therapeutic areas. Operates with comparable patient-recruitment motion and sponsors across the same indications as Meridien.
  • Research Across America: Multi-site SMO operating research facilities across multiple US states, primarily in the South and Midwest. Competes for sponsor trial placements with the same therapeutic-area breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Meridien Research social profiles

Digital presence

Meridien Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Meridien Research leadership team

Management profile

Number of profiles

Profiles1 record

Meridien Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Meridien Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meridien Research

What does Meridien Research do?

Meridien Research operates a dedicated clinical research facility in Winter Park that conducts clinical trials on behalf of pharmaceutical and biotech sponsors. As a member site of the Alcanza Clinical Research network, it recruits and enrolls diverse patient populations across multiple therapeutic areas, executes study protocols, and collects clinical data for sponsors while providing participants with access to investigational treatments.

Is Meridien Research a public or private company?

Meridien Research is a private company. It is classified as unknown and is currently operating.

When was Meridien Research founded?

Meridien Research was founded in 2000. It employs 11 to 50 people.

Where is Meridien Research based?

Meridien Research is headquartered in St. Petersburg, United States, in the North America region.

How does Meridien Research make money?

One revenue line is on record: clinical Research Services.

Who are Meridien Research's main competitors?

Broad incumbents on record are Alcanza Clinical Research, IQVIA, Medpace and ICON plc. Direct peers are Velocity Clinical Research, Wake Research, Flourish Research, Benchmark Research, Accel Research and Research Across America.

Does Meridien Research have an API?

No public API is recorded for Meridien Research.

What industry is Meridien Research in?

Meridien Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales